Sign In
Buy NNVC
$1.31
-0.0100 (-0.758%)
At Close: Jun 23, 2026
Activist investor Bill Ackman makes $2B bet on Meta Platforms
07:10am, Thursday, 12'th Feb 2026
Billionaire activist investor Bill Ackman has taken a roughly $2 billion stake in Meta Platforms Inc (NASDAQ:META, XETRA:FB2A, SIX:FB), making a major bet...
Renalytix shares fall 25% as revenues miss expectations
03:35am, Wednesday, 11'th Feb 2026
Renalytix PLC (AIM:RENX, OTC:RNLXY, FRA:2O9) shares dropped 25% to 4.25p after the company posted first-half revenues of $1.6 million and flagged...
NanoViricides seeks orphan drug status with US FDA for measles treatment
09:16am, Tuesday, 10'th Feb 2026
NanoViricides (NYSE-A:NNVC), a clinical-stage biotechnology company developing broad-spectrum antivirals, said on Tuesday it has filed an application with the US Food and Drug Administration (FDA) for
Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
08:30am, Tuesday, 10'th Feb 2026
SHELTON, CONNECTICUT / ACCESS Newswire / February 10, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the de
NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres
08:30am, Monday, 02'nd Feb 2026
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs th
NanoViricides highlights need for broad-spectrum antivirals amid severe flu season
11:13am, Tuesday, 13'th Jan 2026
NanoViricides (NYSE-A:NNVC), a clinical-stage company developing broad-spectrum antiviral drugs, has highlighted the current influenza season as an example of the need for antivirals capable of target
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs th
Comparing Mallinckrodt (OTCMKTS:MNKKQ) & NanoViricides (NYSE:NNVC)
02:14am, Sunday, 28'th Dec 2025
Mallinckrodt (OTCMKTS:MNKKQ - Get Free Report) and NanoViricides (NYSE: NNVC - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two com
NanoViricides (NYSE:NNVC) Shares Down 4% – Here’s Why
04:06am, Wednesday, 24'th Dec 2025
NanoViricides, Inc. (NYSE: NNVC - Get Free Report) shares dropped 4% during mid-day trading on Tuesday. The company traded as low as $1.20 and last traded at $1.20. Approximately 149,882 shares were t
FTSE 100 Live: Blue chips inch higher ahead of BoE decision, BP replaces CEO
04:06am, Thursday, 18'th Dec 2025
FTSE 100 up 5 points at 9,779 BP replaces CEO after less than 2yrs Currys tops FTSE 350 risers after results 9.06am: Currys good H1 but only 10% of full...
NanoViricides advances Phase 2 trials for broad-spectrum antiviral NV-378 in $17B market: analysts
10:29am, Wednesday, 17'th Dec 2025
NanoViricides (NYSE-A:NNVC) is gearing up to tackle multiple viral threats with Phase 2 trials for its broad-spectrum antiviral NV-378, as analysts at Alliance Global Partners kick off coverage with a
Dow Jones ticks lower, Nasdaq down but Netflix gains as Warner Bros rejects Paramount
05:55am, Wednesday, 17'th Dec 2025
10:50am: Fed’s Waller signals room for rate cuts Federal Reserve Governor Christopher Waller said Wednesday the central bank still has room to cut interest...
NanoViricides advances Phase 2 trials for broad-spectrum antiviral NV-378 in $17B market: analysts
05:26am, Wednesday, 17'th Dec 2025
NanoViricides (NYSE-A:NNVC) is gearing up to tackle multiple viral threats with Phase 2 trials for its broad-spectrum antiviral NV-378, as analysts at...
2 Small-Cap Biotechs That Could Reward Patient Investors
09:52am, Friday, 12'th Dec 2025
Speculative investors and patience rarely go hand in hand. Nevertheless, if you're looking to invest in the small-cap biotech sector, patience is a requirement.
NanoViricides inks regulatory services deal to advance orphan drug strategy for antiviral NV-387
09:20am, Monday, 01'st Dec 2025
NanoViricides (NYSE-A:NNVC) said on Monday it signed a master services agreement with regulatory consulting firm Only Orphans Cote LLC to support the company's orphan drug strategy for its broad-spect
